Clinical Trial

Focal Radiotherapy for Previously Treated Prostate Cancer Patients

Recruiting
View on ClinicalTrials.gov →
Summary
To examine the feasibility, safety and toxicity of focal stereotactic radiation treatment (SBRT) for locally recurrent prostate cancer.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2017-03-02; most recent amendment 2026-02-04.
Status change: Not Yet Recruiting → Recruiting 2017-04-11
Trial Details
NCT Number NCT03073278
Lead Sponsor Royal North Shore Hospital
Collaborators: Northern Sydney and Central Coast Area Health Service
Conditions Locally Recurrent Prostate Cancer
Enrollment 36 participants
Start Date 2017-04-24
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06